Cargando...
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...
Gardado en:
| Publicado en: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/ https://ncbi.nlm.nih.gov/pubmed/34188949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|